Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
18.6M
-
Shares change
-
-2.69M
-
Total reported value, excl. options
-
$612M
-
Value change
-
-$186M
-
Put/Call ratio
-
1.13
-
Number of buys
-
94
-
Number of sells
-
-72
-
Price
-
$32.96
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2021
227 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.6M shares
of 48.9M outstanding shares and own 38.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.66M shares), BlackRock Inc. (2.07M shares), RTW INVESTMENTS, LP (1.62M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1.42M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.13M shares), STATE STREET CORP (786K shares), Bellevue Group AG (753K shares), BAKER BROS. ADVISORS LP (539K shares), GEODE CAPITAL MANAGEMENT, LLC (491K shares), and Nuveen Asset Management, LLC (491K shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.